Nanoscale · 2024 · 14 citations · 36 references
PharmacyMolecular PharmaceuticsOncologyDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer Drug DeliveryCancer NanomedicineCo-delivery SystemsNanomedicineNanoparticle Delivery SystemsNucleic Acid DeliveryCancer NanotherapyChemotherapy DeliveryCyclodextrin-based NanocarriersFenton ReactionFenton-like ReactionsMultifunctional NanoplatformsSupramolecular InteractionsTumor-targeted Drug Delivery
The therapeutic outcome of chemodynamic therapy (CDT) is greatly hindered by the presence of oxidative damage repair proteins (MTH1) inside cancer cells. These oxidative damage repair proteins detoxify the action of radicals generated by Fenton or Fenton-like reactions. Hence, it is extremely important to develop a simple strategy for the downregulation of MTH1 protein inside cancer cells along with the delivery of metal ions into cancer cells. A one-pot host-guest supramolecular approach for the codelivery of MTH1 siRNA and metal ions into a cancer cell is reported. Our approach involves the fabrication of an inclusion complex between cationic β-cyclodextrin and a ferrocene prodrug, which spontaneously undergoes amphiphilicity-driven self-assembly to form spherical nanoparticles (NPs) having a positively charged surface. The cationic surface of the NPs was then explored for the loading of MTH1 siRNA through electrostatic interactions. Using HeLa cells as a representative example, efficient uptake of the NPs, delivery of MTH1 siRNA and the enhanced CDT of the nanoformulation are demonstrated. This work highlights the potential of the supramolecular approach as a simple yet efficient method for the delivery of siRNA across the cell membrane for enhanced chemodynamic therapy.
36
Macroscopic self-assembly through molecular recognition
Akira Harada, Ryosuke Kobayashi, Yoshinori Takashima et al. · Nature Chemistry · 2010 · 794 citations
Stereospecific targeting of MTH1 by (S)-crizotinib as an anticancer strategy
K. Huber, E. Salah, Branka Radic-Sarikas et al. · Nature · 2014 · 390 citations
Kanglei Liu, Zhenqi Jiang, Roger A. Lalancette et al. · Journal of the American Chemical Society · 2022 · 275 citations
Aminoferrocene-Based Prodrugs Activated by Reactive Oxygen Species
Helen Hagen, Paul Marzenell, Elmar Jentzsch et al. · Journal of Medicinal Chemistry · 2011 · 257 citations